In addition, our findings showed that the methylation levels of candidate genes (HIC1, HOXA9, SOX1, DAPK1, RASSF1A, SFRP1, and SPARC) were significantly elevated in patients with ovarian cancer and was highly cancer-specific, which is in concord with the previously published reports. This evidence concerns the gene RASSF1 and ovarian cancer.